The Univida network of centers has chosen Biobarica's Revitalair 430+ hyperbaric chambers to provide hyperbaric oxygen therapy across more than 15 locations in the United States. With over 30 units installed, they are committed to innovative, high-quality treatments to enhance their patients' health.

 

With a commitment to delivering innovative and effective therapeutic solutions, Iván Herrera and Luis Castro, CEO and COO of Univida, along with Medical Director Dr. Orlando Rodriguez, have incorporated hyperbaric oxygen therapy (HBOT) into their network of care centers in the United States.

 

This initiative led to the creation of Unibarica, a strategic alliance between Univida and Biobarica, focused on expanding access to advanced medical treatments based on medium-pressure hyperbaric technology.

 

 

The Revitalair 430+ hyperbaric chambers were selected for their efficacy, safety, and ease of use. This medium-pressure technology is clinically proven, free from adverse effects, and certified as medical equipment in over 20 countries. Additionally, their ergonomic design—featuring a removable stretcher and dual-operation valves—makes them an ideal choice for medical centers that prioritize patient comfort and safety.

 

Ali Yasells, head of the hyperbaric medicine unit at Unibarica, highlighted the growing interest in the therapy's benefits. "Many patients have already begun their treatments and have noticed improvements in their quality of life from the very first sessions", he stated.